132 related articles for article (PubMed ID: 2152975)
1. Breast cancer and estrogen replacement.
N Engl J Med; 1990 Jan; 322(3):201-4. PubMed ID: 2152975
[No Abstract] [Full Text] [Related]
2. Hormone replacement therapy and breast cancer risk.
Melnikow J
J Fam Pract; 1995 Nov; 41(5):501-2. PubMed ID: 7595271
[No Abstract] [Full Text] [Related]
3. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Langer RD
Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
[No Abstract] [Full Text] [Related]
4. [Hormone replacement therapy in menopause].
Breckwoldt M
Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
[No Abstract] [Full Text] [Related]
5. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
Twombly R
J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
[No Abstract] [Full Text] [Related]
6. Pfizer ordered to pay $103m over hormone drugs and breast cancer.
Tanne JH
BMJ; 2009 Nov; 339():b5085. PubMed ID: 19946002
[No Abstract] [Full Text] [Related]
7. Re: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
Wood C; Cline M
J Natl Cancer Inst; 2008 Sep; 100(18):1335; author reply 1335-6. PubMed ID: 18780867
[No Abstract] [Full Text] [Related]
8. Do risks of hormone therapy persist after discontinuation?
J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
[No Abstract] [Full Text] [Related]
9. Women seek alternatives to hormone replacement therapy.
Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
[No Abstract] [Full Text] [Related]
10. The risk of breast cancer after estrogen and estrogen-progestin replacement.
Bergkvist L; Adami HO; Persson I; Hoover R; Schairer C
N Engl J Med; 1989 Aug; 321(5):293-7. PubMed ID: 2546079
[TBL] [Abstract][Full Text] [Related]
11. The estrogen and progestin dilemma: new advice, labeling guidelines.
Bren L
FDA Consum; 2003; 37(2):10-1. PubMed ID: 12715763
[No Abstract] [Full Text] [Related]
12. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
Nachtigall MJ; Smilen SW; Nachtigall RD; Nachtigall RH; Nachtigall LE
Obstet Gynecol; 1992 Nov; 80(5):827-30. PubMed ID: 1328978
[TBL] [Abstract][Full Text] [Related]
13. Progesterone Exposure and Breast Cancer Risk: Understanding the Biological Roots.
Joshi PA; Goodwin PJ; Khokha R
JAMA Oncol; 2015 Jun; 1(3):283-5. PubMed ID: 26181171
[No Abstract] [Full Text] [Related]
14. [Increased risk of breast cancer following estrogen substitution after all? Hormone substitution in peri- and postmenopause--Swedish studies].
von Werder K
Fortschr Med; 1989 Nov; 107(34):723-4. PubMed ID: 2606417
[No Abstract] [Full Text] [Related]
15. Progesterone and Synthetic Progestin Controversies.
Gompel A; Plu-Bureau G
JAMA Oncol; 2015 Oct; 1(7):987. PubMed ID: 26448287
[No Abstract] [Full Text] [Related]
16. Progesterone and Synthetic Progestin Controversies.
Jordan VC; Maximov PY; Fan P
JAMA Oncol; 2015 Oct; 1(7):986-7. PubMed ID: 26448286
[No Abstract] [Full Text] [Related]
17. Estrogen replacement therapy and breast cancer.
Maguire PJ
J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
[TBL] [Abstract][Full Text] [Related]
18. Progesterone and Synthetic Progestin Controversies--Reply.
Joshi PA; Goodwin PJ; Khokha R
JAMA Oncol; 2015 Oct; 1(7):987-8. PubMed ID: 26448288
[No Abstract] [Full Text] [Related]
19. Postmenopausal estrogen and the risk of breast cancer. The need for randomized trials.
Rossouw JE; Harlan WR
Ann Epidemiol; 1994 May; 4(3):255-6. PubMed ID: 8055127
[No Abstract] [Full Text] [Related]
20. Breast cancer risk in postmenopausal women using estrogen-only therapy.
Lyytinen H; Pukkala E; Ylikorkala O
Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]